Trial Profile
Clinical Trials Insight: 700028816
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2009
Price :
$35
*
At a glance
- Drugs MIV 701 (Primary)
- Indications Osteoporosis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Medivir AB
- 27 Nov 2007 New trial record.
- 23 Nov 2007 Interim results reported in a Medivir media release (proof-of-principle attained).